Stockreport

Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 [Yahoo! Finance]

Regen Biopharma, Inc. Common  (RGBP) 
NASDAQ:AMEX Investor Relations: regenbiopharmainc.com/investor-relations.html
PDF the Company will be presenting an update on its application for Orphan Drug status to the U.S. Food and Drug Administration (FDA) for HemaXellerate. This therapy is anti [Read more]